AIM
MD icon

Acrospire Investment Management’s Pediatrix Medical MD Stock Holding History

Acrospire Investment Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-201
Closed -$12K – 842
2017
Q2 		$12K Buy
+201
New +$11.9K 0.01% 1742
2016
Q3 		– Sell
-200
Closed -$14K – 2079
2016
Q2 		$14K Sell
200
-400
-67% -$27.5K 0.01% 1648
2016
Q1 		$39K Buy
+600
New +$39.8K 0.03% 1150

Other funds holding MD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
BHG
Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Acrospire Investment Management's MD Position: Q3 2017 in Review

Acrospire Investment Management sold out of Pediatrix Medical (MD) in Q3 2017, closing a stake of 201 shares — an estimated $12K sold.

Acrospire Investment Management first reported a position in MD in Q1 2016 and held it in 3 quarters. The position peaked at $39K in Q1 2016. 337 funds tracked by Wall St. Rank hold MD as of Q3 2017.

  • Acrospire Investment Management reported no remaining Pediatrix Medical position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 201 Pediatrix Medical shares in Q3 2017, an estimated $12K.
  • Acrospire Investment Management first reported a position in Pediatrix Medical in Q1 2016 and held it in 3 quarters.
  • Acrospire Investment Management's Pediatrix Medical position peaked at $39K in Q1 2016.
  • 337 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.